Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase — Trials · CancerIndex

Clinical trials

Registered studies

28 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7
Recruiting: 3
Ph III recruiting: 1
Growth YoY: —
Industry share: 57%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03895112	MPN-RC 118 AVID200 in Myelofibrosis	completed	Phase 1	21	John MascarenhasOTHER	1	Feb 10, 2023	clinicaltrials
NCT01423851	Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF	completed	Phase 1 / Phase 2	77	NS Pharma, Inc.INDUSTRY	1	Mar 9, 2022	clinicaltrials